Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0000899243-21-004757

Chief Medical Officer acquired 968 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Harris Matthew Scott Chief Medical Officer 2021-01-31 Grant or award +968 $12.14 $11,752 5,037 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Harris Matthew Scott Chief Medical Officer 2021-02-01 Grant or award · Stock Options (option to buy) +90,000 90,000 D: show line 2 in the form
Harris Matthew Scott Chief Medical Officer 2021-02-01 Grant or award · Restricted Stock Units +24,664 24,664 D: show line 3 in the form
Loading xslF345X03/doc4.xml…